FDA recall D-1047-2016

Attix Pharmaceuticals Inc · Class III · drug

Product

Mycophenolate Mofetil, Bulk Powder, Quantity 1000 g, For prescription compounding use and medical manufacturing or processing only, Attix Pharmaceuticals, Toronto, Canada

Reason for recall

cGMP deviation; manufacturer is Not Registered with the Food and Drug Administration

Distribution

CO

Key facts

Status
Terminated
Initiation date
2016-05-18
Report date
2016-06-29
Termination date
2016-07-26
Voluntary/Mandated
Voluntary: Firm initiated
Location
Toronto, N/A, Canada

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1047-2016